Skip to main content
. 2012 Feb 24;3:20. doi: 10.3389/fphar.2012.00020

Table 1.

Levels of hematopoietic growth factors in Gl-PS–SCM and Gl-PS–BMSCM.

Concentration of Gl-PS (μg/ml) G-CSF GM-CSF IL-1β IL-6 SCF
Gl-PS–SCM
0 0.0 ± 0.0 5.9 ± 2.3 12.7 ± 4.8 80.3 ± 6.4 0.0 ± 0.0
25 472.6 ± 53.7a 15.0 ± 3.4a 99.5 ± 12.6a 289.2 ± 22.4a 0.0 ± 0.0
50 634.8 ± 82.1a 26.7 ± 4.9a 169.0 ± 14.7a 439.8 ± 41.0a 0.0 ± 0.0
100 801.3 ± 99.2a 38.7 ± 4.6a 281.4 ± 22.5a 635.7 ± 77.0a 0.0 ± 0.0
200 1070.2 ± 123.0a 50.2 ± 6.3a 479.5 ± 40.7a 857.3 ± 104.6a 0.0 ± 0.0
Gl-PS–BMSCM
0 8.0 ± 3.1 3.2 ± 1.5 5.3 ± 3.1 38.2 ± 5.3 20.3 ± 4.1
25 20.8 ± 4.8a 11.5 ± 2.4a 9.5 ± 3.6 155.7 ± 6.9a 43.2 ± 7.5a
50 38.8 ± 7.3a 18.7 ± 4.8a 7.8 ± 3.1 298.8 ± 15.2a 76.0 ± 10.7a
100 71.2 ± 11.2a 49.2 ± 10.3a 8.2 ± 5.2 797.0 ± 33.3a 92.5 ± 13.6a
200 101.7 ± 20.5a 50.7 ± 17.0a 9.0 ± 4.9 922.2 ± 72.2a 155.6 ± 19.5a

Splenocytes (1 × 107) or bone marrow stromal cells (1 × 106) were cultured with Gl-PS (0–200 μg/ml) for 48 h. Gl-PS-splenocyte-conditioned medium (Gl-PS–SCM) and conditioned medium of bone marrow stromal cells (BMSCM) induced by Gl-PS were collected to measure cytokines by ELISA.

aP < 0.05 versus control (concentration of Gl-PS: 0 μg/ml).